Impact of Diabetes on coronary artery disease burden and subsequent adverse cardiac events

被引：0
|
作者：
Deseive, S. D. C. [1 ]
Straub, R. [1 ]
Kupke, M. [1 ]
Hadamitzky, M. [2 ]
Kitslaar, P. [3 ]
Massberg, S. [1 ]
Hausleiter, J. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 1, Munich, Germany
[2] German Heart Ctr Munich, Klin Radiol & Nukl Med, Munich, Germany
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5814
引用
收藏
页码：1227 / 1228
页数：2
相关论文
共 50 条
  • [21] Lipoprotein(a) and coronary artery disease burden in patients with diabetes
    Salvas, John P.
    Ramchandani, Juhi
    Patel, Purva
    Aridi, Tarek
    Vora, Keyur
    Smolensky, Alexander, V
    Olsen, Kristen
    Dharmakumar, Rohan
    Raman, Subha, V
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2025, 19 (01) : 81 - 82
  • [22] Cardiac scoring systems, coronary artery disease and major adverse cardiovascular events: A scoping review
    Premsagar, Preesha
    Aldous, Colleen
    Esterhuizen, Tonya
    SOUTH AFRICAN FAMILY PRACTICE, 2023, 65 (01)
  • [23] Fractional Flow Reserve Treatment and Major Adverse Cardiac Events in Patients With Coronary Artery Disease
    Rigatelli, Gianluca
    Zuin, Marco
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1565 - 1565
  • [24] Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease
    Grace, Sherry L.
    Medina-Inojosa, Jose R.
    Thomas, Randal J.
    Krause, Heather
    Vickers-Douglas, Kristin S.
    Palmer, Brian A.
    Lopez-Jimenez, Francisco
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2018, 87 (02) : 85 - 94
  • [25] Efficacy and safety of vorapaxar for the prevention of adverse cardiac events in patients with coronary artery disease: a metaanalysis
    Tan, Guangyi
    Chen, Jian
    Liu, Mao
    Yeh, James
    Tang, Wenyi
    Ke, Jianting
    Wu, Wei
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2016, 6 (02) : 101 - 108
  • [26] A NOVEL PREDICTION FOR ADVERSE CARDIAC EVENTS IN PATIENTS WITH NON-OBSTRUCTIVE CORONARY ARTERY DISEASE
    Lee, J.
    Kim, H. J.
    Choi, I
    VALUE IN HEALTH, 2019, 22 : S571 - S571
  • [27] The effect of smoking cessation on major adverse cardiac events in patients with angiographic coronary artery disease
    Zuberi, OR
    Al-Mallah, M
    Hudson, MP
    Khanal, S
    CIRCULATION, 2005, 111 (20) : E343 - E343
  • [28] Sex differences in coronary atherosclerosis progression and major adverse cardiac events in patients with suspected coronary artery disease
    Gu, Hui
    Gao, Yang
    Wang, Haiping
    Hou, Zhihui
    Han, Lei
    Wang, Ximing
    Lu, Bin
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2017, 11 (05) : 367 - 372
  • [29] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, S.
    Ishi, M.
    Otsuka, Y.
    Nakamura, T.
    Tsujita, K.
    Matoba, T.
    Kohro, T.
    Oba, Y.
    Kabutoya, T.
    Imai, Y.
    Kario, K.
    Kiyosue, A.
    Mizuno, Y.
    Nochioka, K.
    Nakayama, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [30] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, So
    Ishii, Masanobu
    Otsuka, Yasuhiro
    Nakamura, Taishi
    Tsujita, Kenichi
    Matoba, Tetsuya
    Kohro, Takahide
    Oba, Yusuke
    Kabutoya, Tomoyuki
    Imai, Yasushi
    Kario, Kazuomi
    Kiyosue, Arihiro
    Mizuno, Yoshiko
    Nochioka, Kotaro
    Nakayama, Masaharu
    Iwai, Takamasa
    Miyamoto, Yoshihiro
    Sato, Hisahiko
    Akashi, Naoyuki
    Fujita, Hideo
    Nagai, Ryozo
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 18
12345